GeneGrafts

About:

Cell therapy for modulating excitable tissues

Website: https://genegrafts.com/

Top Investors: Vertex Ventures, Vertex Ventures Israel, SCP Vitalife Partners, ProSeed Venture Capital Fund, Technion Seed

Description:

GeneGrafts Ltd. is a biotechnology company developing proprietary technology for modulating excitable tissues, such as of brain or heart, by cell therapy. This new paradigm can be used for treatment of various diseases including Parkinson's disease and other neurological disorders or cardiac arrhythmias. They have developed a novel technology platform based on transplantation of cell grafts, isolated from the patient's own body, which defines the ion channels. These grafted cells integrate functionally and structurally with the target organ, and their electrical properties are derived from the expressed ion channels. The electrical properties of target organ are modulated in a predetermined way. This technology is designed for treatment of neurological disorders and cardiac arrhythmias.